Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(7-isobutyl-6-oxo-1-(3-(piperidin-1-yl)propyl)-5,6-dihydro-1H-imidazo(4,5-g)quinoxalin-2-yl)-4-(pyridin-4-yl)benzamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(7-isobutyl-6-oxo-1-(3-(piperidin-1-yl)propyl)-5,6-dihydro-1H-imidazo(4,5-g)quinoxalin-2-yl)-4-(pyridin-4-yl)benzamide
Unique ID
C000601039
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000601039
Entry Term(s)
CTN06 compound
Registry Numbers
0
Previous Indexing
inhibits both Btk and Etk kinases; structure in first source
Heading Mapped to
*Imidazoles
*Quinoxalines
Frequency
1
Source
Cell Death Dis. 2014;5:e1409.
Date of Entry
2015/09/06
Revision Date
2015/09/06
N-(7-isobutyl-6-oxo-1-(3-(piperidin-1-yl)propyl)-5,6-dihydro-1H-imidazo(4,5-g)quinoxalin-2-yl)-4-(pyridin-4-yl)benzamide Preferred
page delivered in 0.006s